(Circulation. 1999;100:461-464.)
© 1999 American Heart Association, Inc.
Brief Rapid Communications |
Desmin Mutation Responsible for Idiopathic Dilated Cardiomyopathy
From the Section of Cardiology (D.L., T.T., O.G., M.A.Q., W.A.Z., R.H., L.L.B., D.L.M., R.R.), Molecular Biology Computational Resource (P.E.B.), Baylor College of Medicine, Houston, Tex.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background—Idiopathic dilated cardiomyopathy, of which
20% of cases are
familial (FDCM), is a primary myocardial disorder characterized by
ventricular dilatation and impaired systolic
function. It is a common cause of heart failure and the need for
cardiac transplantation. Although 6 chromosomal loci responsible for
autosomal dominant FDCM have been mapped by linkage analysis,
none of these genes have been identified. By use of the candidate-gene
approach, actin was identified recently as being responsible for
dilated cardiomyopathy. Considerable evidence
suggests desmin, a muscle-specific intermediate filament, plays a
significant role in cardiac growth and development.
Methods and Results—To determine whether a defect of desmin
induces dilated cardiomyopathy, 44 probands with
FDCM underwent clinical evaluation and DNA analysis.
Diagnostic criteria, detected by
echocardiography, consisted of
ventricular dimension of 
2.7 cm/m2 with an
ejection fraction 
50% in the absence of other potential causes.
After amplification by polymerase chain reaction, the exons of the
desmin gene were sequenced. A missense desmin mutation, Ile451Met,
which cosegregates with FDCM without clinically evident skeletal muscle
abnormalities, was identified in a 4-generation family but was not
detected in 460 unrelated healthy individuals.
Conclusions—A novel missense mutation of desmin, Ile451Met, was identified as the genetic cause of idiopathic dilated cardiomyopathy. This finding is of particular significance because this is the first mutation detected in the desmin tail domain, and the function of the desmin tail remains unknown. Because this mutation leads to a restricted cardiac phenotype in the family studied in the present report, it suggests that the tail of desmin plays an important functional role in cardiac tissue.
Key Words: cardiomyopathy • genes • desmin
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Dilated cardiomyopathy (DCM) is the most common form of primary cardiac muscle disease; it is several times more common than the hypertrophic form. The estimated prevalence of DCM in the United States is 36.5 per 100 000 individuals.1 Clinically, DCM is characterized by ventricular chamber enlargement, systolic dysfunction, sudden death, and heart failure. Heart failure due to DCM is a lethal disease, with a 5-year mortality rate of 75%. Cardiac transplantation is the only cure for this disease.2 Approximately 50% of DCM cases are idiopathic, of which at least 20% are familial.1 Progress in unraveling the genetic causes of idiopathic DCM has been slow compared with that for hypertrophic cardiomyopathy. By use of genetic linkage analysis, 6 chromosomal loci have been mapped for autosomal dominant DCM, but none of the genes have been identified. In 1998, by use of the candidate-gene approach, actin was shown to be responsible for idiopathic DCM.3 In musculoskeletal disorders such as Duchenne muscular dystrophy, which are associated with DCMs, the responsible genes are dystrophin,
-dystroglycan, and -sarcoglycan, all of which are cytoskeletal
proteins.4 Desmin, a cytoskeletal protein that forms
intermediate filaments specific for muscle, has been shown to be
associated with cardiac and skeletal abnormalities.5
Accordingly, because the families with FDCM that we studied were too
small to provide adequate power for linkage analysis, we
adopted the candidate-gene approach and sequenced the DNA of 44
probands with FDCM for the actin and desmin genes. No actin mutation
was found, but a missense mutation (Ile451Met) in desmin was found in
the proband of family 20-032, which has DCM without any skeletal
abnormalities. The remainder of the family of this proband was
subsequently studied, and analysis of the data showed the
mutation cosegregates with DCM as an autosomal dominant trait. |
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Clinical Evaluation
Probands with FDCM and family members were evaluated by detailed history and physical examination, 12-lead ECG, M-mode echocardiography, 2D Doppler echocardiography, and other special tests if necessary. Informed written consent was obtained from each individual, and data were collected according to the guidelines of Baylor College of Medicine (Houston, Tex). The diagnostic criteria for DCM, as used previously,6 consisted of an ejection fraction
50% on echocardiography, regional
fraction shortening 27% on M-mode analysis, or both in the
presence of a left ventricular internal
diastolic dimension 2.7 cm/m2 of
body surface area in individuals in whom other common causes of DCM
(coronary heart disease, myocarditis, and hypertension) were
excluded. Blood samples were collected for immediate DNA
analysis and plasma creatine kinase assay, and the lymphocytes
were transformed into immortal cell lines for a renewable source of
DNA.
Mutation Detection and Analysis
Genomic DNA extracted from whole blood cells by the salting-out
procedure6 served as the template for polymerase chain
reaction (PCR) amplification of exons and flanking intron sequences of
the candidate genes. Seven sets of primers were designed and
synthesized to flank the 9 exons of the human desmin gene according to
its published genomic DNA sequence.7 The sequence of these
primers was as follows: exon 1F, 5'-CTGATGTCAGGAGGGATACA-3'; exon 1R,
5'-AGAAGGCAGGTGGTGACAG-3'; exon 2-3F, 5'-CTTTATCACCCGCAACTGTC-3'; exon
2-3R, 5'-TATTCCCA-GCCAGAGCCTC-3'; exon 4-5F,
5'-AGGCTCTGGCTGG-GAATAG-3; exon 4-5R,
5'-ATGGCCAAGGTCACAAAGTG-3'; exon 6F, 5'-TTTGGGCTGCTAGTGTCCTC-3'; exon
6R, 5'-ATC-AGTAATCTCGAGCCTCC-3'; exon 7F,
5'-ATGGTCTCGA-TCTCCTGACC-3'; exon 7R,
5'-CCCTTTTCTTCCCTAGCTC-3'; exon 8F, 5'-GAAGTAACAAGCCTGTCTTG-3; exon
8R, 5'-GAT-CTCTCTTGCCCACTAGC-3'; exon 9F,
5'-CGTCATCCTGC-TAGCACATG-3'; and exon 9R,
5'-CTGGCAGTCAAGAC-AACAGG-3'. PCR product sizes of these
fragments are 709, 385, 621, 361, 299, 329, and 859 base pairs,
respectively. PCR for amplification of these exons was performed with
200 ng of genomic DNA, 20 mmol/L Tris-HCl (pH 8.4), 50 mmol/L
KCl, 1.5 mmol/L MgCl, 50 µmol/L of each
deoxynucleotide triphosphate, 0.2 µmol/L forward
primer, 0.2 µmol/L reverse primer, and 2.5 U of Taq polymerase
in a final volume of 50 µL. The PCR product was purified with a
Qiagen PCR purification kit and sequenced on an ABI model 310 genetic
analyzer and Big Dye Terminator sequencing kit (Perkin-Elmer).
Protein secondary-structure prediction was performed by use of the
Garnier-Osguthorpe-Robson algorithm with the Wisconsin Package version
10.0, Genetics Computer Group.8
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Clinical Findings
The pedigree (Figure 1
) consisted of
28 white individuals extending through 4 generations. Nine
individuals had died before identification of the family, leaving only
2 living affected individuals and 2 others with the mutation without
any clinical phenotype. The proband (III:10) had cardiomegaly
and chronic cardiac failure for >5 years with a left
ventricular ejection fraction of 40% and diffuse
hypokinesis. The son of the proband (IV:2) has cardiomegaly and a left
ventricular ejection fraction of 45%. The paternal
grandfather of the proband had chronic cardiac failure for >2 decades
and died at age 65 years. The 3 cousins of the proband (III:1, III:2,
and III:3) and offspring of II:2 died between the ages of 15 and 37
years and had heart failure before death. There was no evidence to
suggest II:2 and II:3 were affected with the disease, and thus they are
referred to as obligate carriers. There was no clinical evidence of
skeletal muscle involvement on physical examination and no symptoms to
suggest peripheral muscle involvement. Plasma creatine
kinase activity in each individual was consistently in the
normal range (<120 IU/L).
|
Missense Mutation in Desmin Gene
A missense mutation, Ile451Met, in exon 8 of the desmin gene was
found in the proband of family 20-032 by sequence analysis. The
mutation results from a cytosine (C) substitution for guanine
(G) at nucleotide (nt) 1353 (GenBank accession number
AF137053) (Figure 2A). This base change
created a restriction site for NcoI, which was used to
screen all available members. The mutation cosegregated with all
affected individuals. DNA analysis of 460 unrelated control
whites (920 chromosomes) failed to show this mutation.
|
Isoleucine, replaced by the mutation, is highly conserved in the desmin gene across species including human, mouse, rat, chicken, golden hamster, and amphibians. This isoleucine is also a part of a 9-amino-acid motif (IKTIETRDG) that is highly conserved from humans to fish and between different type III intermediate filaments.9
Isoleucine is a nonpolar hydrophobic amino acid, whereas
methionine is a polar neutral amino acid. The
isoleucine-to-methionine substitution induces a dramatic change
in the secondary structure of the desmin tail region based on the
Garnier-Osguthorpe-Robson prediction; specifically, the mutation
removes a predicted turn and replaces a probable ß-sheet with an
extension of the -helix in the preceding region (Figure 2B
.)
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
We identified a cytosine-to-guanine substitution in exon 8 of the desmin gene in a 4-generation family with affected members having DCM manifested by left ventricular dilatation, heart failure, and sudden death. This change in the DNA sequence substitutes methionine for isoleucine at codon 451 (Ile451Met) in the tail domain of human desmin. The altered DNA sequence is considered a disease-causing mutation (FDCM) rather than a rare polymorphism for the following reasons: (1) the mutation was present in all affected family members; (2) the mutation was not present on 920 chromosomes from 460 unrelated normal subjects; (3) the mutation replaces a highly conserved amino acid, isoleucine, at codon 451 (Ile451Met) in the tail domain of human desmin; and (4) the amino acid substitution caused by the mutation is predicted to significantly alter the secondary structure of desmin, as shown in Figure 2B
.
Furthermore, elimination of the desmin gene in the mouse has been shown
to be associated with skeletal and cardiac myopathies.5
Penetrance was incomplete, with 2 female members (III:14 and III:16)
having the mutation without obvious phenotype. It is of note
that all of the individuals affected, living or dead, were male.
Whether this reflects sex-related penetrance or is simply a chance
observation remains to be determined. Desmin is a muscle-specific 53-kDa subunit of the class III intermediate filament. It is a part of the cytoskeleton of all 3 muscle types and forms connections between the nuclear and plasma membranes.5 9 The tail domain undergoes posttranslational modifications by phosphorylation and glycosylation, regulating dynamic aspects of intermediate filament organization and structure during the cell cycle. Desmin is found at the Z lines and intercalated disk and is believed to play a role in the attachment or stabilization of the sarcomere. Recently, desmin mutations have been recognized as a cause of skeletal myopathies with cardiac involvement, manifested predominantly as conduction disorders and restrictive cardiomyopathy.10 The family in the present study, in contrast, has no discernible clinical involvement of the skeletal or smooth muscles but has a profound DCM. Furthermore, plasma creatine kinase activity, a highly sensitive marker of familial skeletal muscle disease, was normal, even for carriers. Interestingly, the previous mutations associated with skeletal muscle disorders are in the rod domain, whereas our mutation is in the carboxy tail domain of the protein, a region whose function is undetermined. This may reflect a distinct functional domain with a binding site specific for cardiac proteins. Additional study should provide insight into the pathogenesis of DCM and determine the specific function of the carboxy-terminal portion of desmin.
The actin mutations responsible for FDCM were located in the actin domains, which are immobilized and attached to the Z band or intercalated disc, and thus are involved with transmission of contractile force rather than affecting the myosin cross bridges and the generation of force.3 Similarly, desmin attaches to the sarcomere Z band, the nuclear membrane, and other organelles and is known to serve as a means for the transmission of force and other signals.5 9 This may be the common molecular basis whereby mutations in both actin and desmin induce a similar disease phenotype. It is reasonable to postulate that both desmin and actin provide a scaffolding role in the growth and maintenance of the sarcomere, and thereby the mutant leads to an impaired growth response, namely, DCM.
|
Acknowledgments |
|---|
This work was supported in part by grants from the National Heart, Lung, and Blood Institute, Specialized Centers of Research (P50-HL54313), and the National Institutes of Health Training Center in Molecular Cardiology (T32-HLO7706). We greatly appreciate the secretarial assistance of Debora Weaver and Valorie Garza in the preparation of the manuscript and figures.
|
Footnotes |
|---|
Reprint requests to Robert Roberts, MD, Don W. Chapman Professor of Medicine, Professor of Medicine and Cell Biology, Department of Medicine, Section of Cardiology, 6550 Fannin, MS SM677, Baylor College of Medicine, Houston, TX 77030.
Received February 12, 1999; revision received May 20, 1999; accepted June 9, 1999.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, Burnett JC, Rodeheffer RJ, Chesebro JH, Tazelaar HD. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992;326:77–82.[Abstract]
2.
Abraham WT, Bristow MR. Specialized centers for heart
failure management. Circulation. 1997;96:2755–2757.
3.
Olson TM, Michels VV, Thibodeau SN, Tai Y-S, Keating
MT. Actin mutations in dilated cardiomyopathy, a
heritable form of heart failure. Science. 1998;280:750–752.
4.
Bies RD, Maeda M, Roberds SL, Holder E, Bohlmeyer T,
Young JB, Campbell KP. A 5' dystrophin duplication mutation causes
membrane deficiency of -dystroglycan in a family with X-linked
cardiomyopathy. Am J Hum Genet. 1997;29:3175–3188.
5.
Milner DJ, Weitzer G, Tran D, Bradley A, Capetanaki Y.
Disruption of muscle architecture and myocardial degeneration in mice
lacking desmin. J Cell Biol. 1996;134:1255–1270.
6.
Durand JB, Bachinski LL, Beiling L, Czernuszewicz GZ,
Abchee AB, Yu QT, Tapscott T, Hill R, Ifegwu J, Marian AJ, Brugada R,
Daiger S, Gregortich JM, Quinones M, Anderson J, Towbin JA, Roberts R.
Localization of a gene responsible for familial idiopathic dilated
cardiomyopathy to chromosome 1q32.
Circulation. 1995;92:3387–3389.
7. Li ZL, Lilienbaum A, Butler-Browne G, Paulin D. Human desmin-coding gene: complete nucleotide sequence, characterization and regulation of expression during myogenesis and development. Gene. 1989;78:243–254.[Medline] [Order article via Infotrieve]
8. Garnier J, Osguthorpe DJ, Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol. 1978;120:97–120.[Medline] [Order article via Infotrieve]
9. Fuchs E, Weber K. Intermediate filaments: structure, dynamics, function and disease. Annu Rev Biochem. 1994;63:345–382.[Medline] [Order article via Infotrieve]
10. Goldfarb LG, Park K-Y, Cervenakova L, Gorokhova S, Lee H-S, Vasconcelos O, Nagle JW, Semino-Mora C, Sivakumar K, Dalakas MC. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet. 1998;19:402–403.Considerable evidence suggests desmin, a muscle-specific intermediate filament, plays a significant role in cardiac growth and development. To determine whether a defect of this gene induces dilated cardiomyopathy, 44 probands with familial dilated cardiomyopathy (FDCM) were studied for mutations by DNA sequencing. A missense mutation, Ile451Met, was identified in a 4-generation family but was not detected in 460 unrelated healthy individuals. The mutation affects a highly conserved amino acid in the desmin tail domain and cosegregates with FDCM without clinically evident skeletal muscle abnormalities. These results suggest that the desmin mutation is one of the genetic causes of FDCM.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  A Luk, E Ahn, G S Soor, and J Butany Dilated cardiomyopathy: a review J. Clin. Pathol., March 1, 2009; 62(3): 219 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zheng, H. Cheng, X. Li, J. Zhang, L. Cui, K. Ouyang, L. Han, T. Zhao, Y. Gu, N. D. Dalton, et al. Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death Hum. Mol. Genet., February 15, 2009; 18(4): 701 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mavroidis, P. Panagopoulou, I. Kostavasili, N. Weisleder, and Y. Capetanaki A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization FASEB J, September 1, 2008; 22(9): 3318 - 3327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-F. Chen, E. P. Murchison, R. Tang, T. E. Callis, M. Tatsuguchi, Z. Deng, M. Rojas, S. M. Hammond, M. D. Schneider, C. H. Selzman, et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure PNAS, February 12, 2008; 105(6): 2111 - 2116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Walter, P. Reilich, A. Huebner, D. Fischer, R. Schroder, M. Vorgerd, W. Kress, C. Born, B. G. Schoser, K. H. Krause, et al. Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P Brain, June 1, 2007; 130(6): 1485 - 1496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R.G. Taylor, D. Slavov, L. Ku, A. Di Lenarda, G. Sinagra, E. Carniel, K. Haubold, M. M. Boucek, D. Ferguson, S. L. Graw, et al. Prevalence of Desmin Mutations in Dilated Cardiomyopathy Circulation, March 13, 2007; 115(10): 1244 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Portig, A. Wilke, M. Freyland, M.-J. Wolf, A. Richter, V. Ruppert, S. Pankuweit, and B. Maisch Familial inflammatory dilated cardiomyopathy Eur J Heart Fail, December 1, 2006; 8(8): 816 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lapouge, L. Fontao, M.-F. Champliaud, F. Jaunin, M. A. Frias, B. Favre, D. Paulin, K. J. Green, and L. Borradori New insights into the molecular basis of desmoplakinand desmin-related cardiomyopathies J. Cell Sci., December 1, 2006; 119(23): 4974 - 4985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Richard, E. Villard, P. Charron, and R. Isnard The Genetic Bases of Cardiomyopathies J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A79 - A89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Donahue, D. A. Marchuk, and H. A. Rockman Redefining Heart Failure: The Utility of Genomics J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1289 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Arbustini, M. Pasotti, A. Pilotto, C. Pellegrini, M. Grasso, S. Previtali, A. Repetto, O. Bellini, G. Azan, M. Scaffino, et al. Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects Eur J Heart Fail, August 1, 2006; 8(5): 477 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Powell The ubiquitin-proteasome system in cardiac physiology and pathology Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H1 - H19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Muntoni, G. Bonne, L. G. Goldfarb, E. Mercuri, R. J. Piercy, M. Burke, R. B. Yaou, P. Richard, D. Recan, A. Shatunov, et al. Disease severity in dominant Emery Dreifuss is increased by mutations in both emerin and desmin proteins Brain, May 1, 2006; 129(5): 1260 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. McCulloch and J. H. Omens Myocyte Shearing, Myocardial Sheets, and Microtubules Circ. Res., January 6, 2006; 98(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Gard, K. Yamada, K. G. Green, B. C. Eloff, D. S. Rosenbaum, X. Wang, J. Robbins, R. B. Schuessler, K. A. Yamada, and J. E. Saffitz Remodeling of gap junctions and slow conduction in a mouse model of desmin-related cardiomyopathy Cardiovasc Res, August 15, 2005; 67(3): 539 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mirza, S. Marston, R. Willott, C. Ashley, J. Mogensen, W. McKenna, P. Robinson, C. Redwood, and H. Watkins Dilated Cardiomyopathy Mutations in Three Thin Filament Regulatory Proteins Result in a Common Functional Phenotype J. Biol. Chem., August 5, 2005; 280(31): 28498 - 28506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Mounkes, S. V. Kozlov, J. N. Rottman, and C. L. Stewart Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice Hum. Mol. Genet., August 1, 2005; 14(15): 2167 - 2180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Mahon, R. T. Murphy, C. A. MacRae, A. L.P. Caforio, P. M. Elliott, and W. J. McKenna Echocardiographic Evaluation in Asymptomatic Relatives of Patients with Dilated Cardiomyopathy Reveals Preclinical Disease Ann Intern Med, July 19, 2005; 143(2): 108 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Burkett and R. E. Hershberger Clinical and genetic issues in familial dilated cardiomyopathy J. Am. Coll. Cardiol., April 5, 2005; 45(7): 969 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hayashi, T. Arimura, M. Itoh-Satoh, K. Ueda, S. Hohda, N. Inagaki, M. Takahashi, H. Hori, M. Yasunami, H. Nishi, et al. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2192 - 2201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Karkkainen, T. Helio, P. Jaaskelainen, R. Miettinen, P. Tuomainen, K. Ylitalo, M. Kaartinen, E. Reissell, L. Toivonen, M. S. Nieminen, et al. Two novel mutations in the {beta}-myosin heavy chain gene associated with dilated cardiomyopathy Eur J Heart Fail, December 1, 2004; 6(7): 861 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Zemljic-Harpf, S. Ponrartana, R. T. Avalos, M. C. Jordan, K. P. Roos, N. D. Dalton, V. Q. Phan, E. D. Adamson, and R. S. Ross Heterozygous Inactivation of the Vinculin Gene Predisposes to Stress-Induced Cardiomyopathy Am. J. Pathol., September 1, 2004; 165(3): 1033 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sanbe, H. Osinska, J. E. Saffitz, C. G. Glabe, R. Kayed, A. Maloyan, and J. Robbins Desmin-related cardiomyopathy in transgenic mice: A cardiac amyloidosis PNAS, July 6, 2004; 101(27): 10132 - 10136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Di Somma, M.P. Di Benedetto, G. Salvatore, L. Agozzino, F. Ferranti, S. Esposito, P. La Dogana, M.I. Scarano, G. Caputo, M. Cotrufo, et al. Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure Eur J Heart Fail, June 1, 2004; 6(4): 389 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Karkkainen, T. Helio, R. Miettinen, P. Tuomainen, P. Peltola, J. Rummukainen, K. Ylitalo, M. Kaartinen, J. Kuusisto, L. Toivonen, et al. A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy Eur. Heart J., May 2, 2004; 25(10): 885 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Goldfarb, P. Vicart, H. H. Goebel, and M. C. Dalakas Desmin myopathy Brain, April 1, 2004; 127(4): 723 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Arimura, T. Hayashi, H. Terada, S.-Y. Lee, Q. Zhou, M. Takahashi, K. Ueda, T. Nouchi, S. Hohda, M. Shibutani, et al. A Cypher/ZASP Mutation Associated with Dilated Cardiomyopathy Alters the Binding Affinity to Protein Kinase C J. Biol. Chem., February 20, 2004; 279(8): 6746 - 6752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Pyle and R. J. Solaro At the Crossroads of Myocardial Signaling: The Role of Z-Discs in Intracellular Signaling and Cardiac Function Circ. Res., February 20, 2004; 94(3): 296 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Vatta, B. Mohapatra, S. Jimenez, X. Sanchez, G. Faulkner, Z. Perles, G. Sinagra, J.-H. Lin, T. M. Vu, Q. Zhou, et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction J. Am. Coll. Cardiol., December 3, 2003; 42(11): 2014 - 2027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Sebillon, C Bouchier, L D Bidot, G Bonne, K Ahamed, P Charron, V Drouin-Garraud, A Millaire, G Desrumeaux, A Benaiche, et al. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations J. Med. Genet., August 1, 2003; 40(8): 560 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Scopacasa, V. P. A. Teixeira, and K. G. Franchini Colchicine attenuates left ventricular hypertrophy but preserves cardiac function of aortic-constricted rats J Appl Physiol, April 1, 2003; 94(4): 1627 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. G. Taylor, P. R. Fain, G. Sinagra, M. L. Robinson, A. D. Robertson, E. Carniel, A. Di Lenarda, T. J. Bohlmeyer, D. A. Ferguson, G. L. Brodsky, et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations J. Am. Coll. Cardiol., March 5, 2003; 41(5): 771 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Konno, M. Shimizu, H. Ino, T. Matsuyama, M. Yamaguchi, H. Terai, K. Hayashi, T. Mabuchi, M. Kiyama, K. Sakata, et al. A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients J. Am. Coll. Cardiol., March 5, 2003; 41(5): 781 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Doevendans Genetic Polymorphisms and Cardiac Failure Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 23 - 29. [PDF]
|
|
|
|
|
|
F. Chen, R. Chang, M. Trivedi, Y. Capetanaki, and V. L. Cryns Caspase Proteolysis of Desmin Produces a Dominant-negative Inhibitor of Intermediate Filaments and Promotes Apoptosis J. Biol. Chem., February 21, 2003; 278(9): 6848 - 6853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.E. Bowles The molecular biology of dilated cardiomyopathy Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I2 - I7. [Abstract] [PDF]
|
|
|
|
|
|
A. G Schmidt, J. Zhai, A. N Carr, M. J Gerst, J. N Lorenz, P. Pollesello, A. Annila, B. D Hoit, and E. G Kranias Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure Cardiovasc Res, November 1, 2002; 56(2): 248 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fatkin and R. M. Graham Molecular Mechanisms of Inherited Cardiomyopathies Physiol Rev, October 1, 2002; 82(4): 945 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Olson, M. L. Karst, F. G. Whitby, and D. J. Driscoll Myosin Light Chain Mutation Causes Autosomal Recessive Cardiomyopathy With Mid-Cavitary Hypertrophy and Restrictive Physiology Circulation, May 21, 2002; 105(20): 2337 - 2340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Crispell, E. L. Hanson, K. Coates, W. Toy, and R. E. Hershberger Periodic rescreening is indicated for family members at risk of developing familial dilated cardiomyopathy J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1503 - 1507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Stypmann, K. Glaser, W. Roth, D. J. Tobin, I. Petermann, R. Matthias, G. Monnig, W. Haverkamp, G. Breithardt, W. Schmahl, et al. Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L PNAS, April 18, 2002; (2002) 92637699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mavroidis and Y. Capetanaki Extensive Induction of Important Mediators of Fibrosis and Dystrophic Calcification in Desmin-Deficient Cardiomyopathy Am. J. Pathol., March 1, 2002; 160(3): 943 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Mahon, B. P. Madden, A. L. P. Caforio, P. M. Elliott, A. J. Haven, B. E. Keogh, M. J. Davies, and W. J. McKenna Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy J. Am. Coll. Cardiol., February 6, 2002; 39(3): 455 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Balogh, M Merisckay, Z Li, D Paulin, and A Arner Hearts from mice lacking desmin have a myopathy with impaired active force generation and unaltered wall compliance Cardiovasc Res, February 1, 2002; 53(2): 439 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Olson, S. Illenberger, N. Y. Kishimoto, S. Huttelmaier, M. T. Keating, and B. M. Jockusch Metavinculin Mutations Alter Actin Interaction in Dilated Cardiomyopathy Circulation, January 29, 2002; 105(4): 431 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Morimoto, Q.-W. Lu, K. Harada, F. Takahashi-Yanaga, R. Minakami, M. Ohta, T. Sasaguri, and I. Ohtsuki Ca2+-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy PNAS, January 1, 2002; (2002) 22628899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Miyamoto, H. Akita, N. Shiga, E. Takai, C. Iwai, K. Mizutani, H. Kawai, A. Takarada, and M. Yokoyama Frequency and clinical characteristics of dilated cardiomyopathy caused by desmin gene mutation in a Japanese population Eur. Heart J., December 2, 2001; 22(24): 2284 - 2289. [Abstract] [PDF]
|
|
|
|
|
|
D. Li, G. Z. Czernuszewicz, O. Gonzalez, T. Tapscott, A. Karibe, J.-B. Durand, R. Brugada, R. Hill, J. M. Gregoritch, J. L. Anderson, et al. Novel Cardiac Troponin T Mutation as a Cause of Familial Dilated Cardiomyopathy Circulation, October 30, 2001; 104(18): 2188 - 2193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Su, A. Yao, I. Zubair, K. Sugishita, M. Ritter, F. Li, J. J. Hunter, K. R. Chien, and W. H. Barry Effects of deletion of muscle LIM protein on myocyte function Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2665 - H2673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, H. Osinska, G. W. Dorn II, M. Nieman, J. N. Lorenz, A. M. Gerdes, S. Witt, T. Kimball, J. Gulick, and J. Robbins Mouse Model of Desmin-Related Cardiomyopathy Circulation, May 15, 2001; 103(19): 2402 - 2407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ichida, S. Tsubata, K. R. Bowles, N. Haneda, K. Uese, T. Miyawaki, W. J. Dreyer, J. Messina, H. Li, N. E. Bowles, et al. Novel Gene Mutations in Patients With Left Ventricular Noncompaction or Barth Syndrome Circulation, March 6, 2001; 103(9): 1256 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schweitzer, M. Klymkowsky, R. Bellin, R. Robson, Y Capetanaki, and R. Evans Paranemin and the organization of desmin filament networks J. Cell Sci., January 3, 2001; 114(6): 1079 - 1089. [Abstract] [PDF]
|
|
|
|
|
|
A. Gavazzi, A. Repetto, L. Scelsi, C. Inserra, M.L. Laudisa, C. Campana, C. Specchia, B. Dal Bello, M. Diegoli, L. Tavazzi, et al. Evidence-based diagnosis of familial non-X-linked dilated cardiomyopathy. Prevalence, inheritance and characteristics Eur. Heart J., January 1, 2001; 22(1): 73 - 81. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Kamisago, S. D. Sharma, S. R. DePalma, S. Solomon, P. Sharma, B. McDonough, L. Smoot, M. P. Mullen, P. K. Woolf, E. D. Wigle, et al. Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy N. Engl. J. Med., December 7, 2000; 343(23): 1688 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Di Somma, M Marotta, G Salvatore, G Cudemo, G Cuda, F De Vivo, M P Di Benedetto, F Ciaramella, G Caputo, and O de Divitiis Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans Heart, December 1, 2000; 84(6): 659 - 667. [Abstract] [Full Text]
|
|
|
|
|
|
C.A. MacRae Genetics and dilated cardiomyopathy: limitations of candidate gene strategies Eur. Heart J., November 2, 2000; 21(22): 1817 - 1819. [PDF]
|
|
|
|
|
|
E. Arbustini, P. Morbini, A. Pilotto, A. Gavazzi, and L. Tavazzi Familial dilated cardiomyopathy: from clinical presentation to molecular genetics Eur. Heart J., November 2, 2000; 21(22): 1825 - 1832. [PDF]
|
|
|
|
|
|
F Tesson, N Sylvius, A Pilotto, L Dubosq-Bidot, M Peuchmaurd, C Bouchier, A Benaiche, L Mangin, P Charron, A Gavazzi, et al. Epidemiology of desmin and cardiac actin gene mutations in a European population of dilated cardiomyopathy Eur. Heart J., November 2, 2000; 21(22): 1872 - 1876. [Abstract] [PDF]
|
|
|
|
|
|
M KOMAJDA Genetics of dilated cardiomyopathy: a molecular maze? Heart, November 1, 2000; 84(5): 463 - 464. [Full Text]
|
|
|
|
|
|
N G Mahon, A S Coonar, S Jeffery, F Coccolo, J Akiyu, B Zal, R Houlston, G E Levin, C Baboonian, W J McKenna, et al. Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy Heart, November 1, 2000; 84(5): 541 - 547. [Abstract] [Full Text]
|
|
|
|
|
|
K.-Y. Park, M. C Dalakas, H. H Goebel, V. J Ferrans, C. Semino-Mora, S. Litvak, K. Takeda, and L. G Goldfarb Desmin splice variants causing cardiac and skeletal myopathy J. Med. Genet., November 1, 2000; 37(11): 851 - 857. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Sugawara, K. Kato, M. Komatsu, C. Wada, K. Kawamura, S. Shindo, N. Yoshioka, K. Tanaka, S. Watanabe, and I. Toyoshima A novel de novo mutation in the desmin gene causes desmin myopathy with toxic aggregates Neurology, October 10, 2000; 55(7): 986 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Mayosi, E. Blair, H. Watkins, D. Li, T. Tapscott, O. Gonzalez, M. A. Quinones, W. A. Zoghbi, R. Hill, L. L. Bachinski, et al. Dilated Cardiomyopathy and the Desmin Gene Response Circulation, September 26, 2000; 102 (13): e100 - e101. [Full Text] [PDF]
|
|
|
|
|
|
R. Roberts A perspective: the new millennium dawns on a new paradigm for cardiology--molecular genetics J. Am. Coll. Cardiol., September 1, 2000; 36(3): 661 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Goebel and I. A.P Warlo Topical Review: Progress in Desmin-Related Myopathies J Child Neurol, September 1, 2000; 15(9): 565 - 572. [Abstract] [PDF]
|
|
|
|
|
|
J. Schonberger, H. Levy, E. Grunig, S. Sangwatanaroj, D. Fatkin, C. MacRae, H. Stacker, C. Halpin, R. Eavey, E. F. Philbin, et al. Dilated Cardiomyopathy and Sensorineural Hearing Loss : A Heritable Syndrome That Maps to 6q23-24 Circulation, April 18, 2000; 101(15): 1812 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Dalakas, K.-Y. Park, C. Semino-Mora, H. S. Lee, K. Sivakumar, and L. G. Goldfarb Desmin Myopathy, a Skeletal Myopathy with Cardiomyopathy Caused by Mutations in the Desmin Gene N. Engl. J. Med., March 16, 2000; 342(11): 770 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Brodsky, F. Muntoni, S. Miocic, G. Sinagra, C. Sewry, and L. Mestroni Lamin A/C Gene Mutation Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement Circulation, February 8, 2000; 101(5): 473 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Morimoto, Q.-W. Lu, K. Harada, F. Takahashi-Yanaga, R. Minakami, M. Ohta, T. Sasaguri, and I. Ohtsuki Ca2+-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy PNAS, January 22, 2002; 99(2): 913 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Stypmann, K. Glaser, W. Roth, D. J. Tobin, I. Petermann, R. Matthias, G. Monnig, W. Haverkamp, G. Breithardt, W. Schmahl, et al. Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L PNAS, April 30, 2002; 99(9): 6234 - 6239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Frey, J. A. Richardson, and E. N. Olson Calsarcins, a novel family of sarcomeric calcineurin-binding proteins PNAS, December 19, 2000; 97(26): 14632 - 14637. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||